Deutsche Bank upgraded AstraZeneca (AZN) to Hold from Sell with an unchanged price target of 10,500 GBp. The firm cites valuation for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback